MAIA Biotechnology, Inc. MAIA
Biotechnology: Pharmaceutical Preparations · IPO 2022 · data as of November 13, 2026
MAIA Biotechnology, Inc. (MAIA) is a healthcare company listed in the US with a market value of about $62M.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -946%.
About MAIA Biotechnology
MAIA Biotechnology is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2022. It was profitable in 0 of the last 5 years in our data. Its share count rose by 246% over three years (dilution for shareholders).
Score: 0.6 / 5
Checks passed
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | — |
| Net income | -$22M | -$23M | -$20M | -$16M | -$13M |
| Free cash flow | — | — | -$13M | — | — |
| EPS (diluted) | $-0.70 | $-1.05 | $-1.49 | $-1.75 | $-2.37 |
| Net margin | — | — | — | — | — |
| ROIC | -807.0% | -368.6% | -3339.0% | -150.2% | -67.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does MAIA Biotechnology pay a dividend?
Not currently.
Is MAIA Biotechnology a good stock to buy?
We do not give buy or sell advice. MAIA Biotechnology scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.